pocketful logo
Fermenta Biotech Ltd logo

Fermenta Biotech Ltd

NSE: BSE: 506414

₹336.60

(-0.80%)

Fri, 20 Mar 2026, 03:05 pm

Fermenta Biotech EV/EBITDA Ratio

Particulars20052006200720082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio32.335.826.224.234.983.515.2126.8814.81294.61017.4619.436.4310.3115.8738.410010.38
Price to book ratio1.050.700.560.310.660.770.900.880.881.041.231.225.263.011.9821.590.981.512.20
Price to sales ratio2.261.420.960.4411.361.140.960.840.961.031.102.251.922.151.941.490.881.311.70
Price to cash flow ratio3.727.954.333.2028.0403.306.339.0412.91001410.3633.1614.4820.373.144.7524.57
Enterprise value603.79M436.4M462.81M325.42M593.46M1.01B1.2B1.38B1.64B2.09B2.7B2.87B8.06B8.71B8.05B9.09B7.98B4.64B5.12B8.37B
Enterprise value to EBITDA ratio17.81014.6249.1811.2012.258.936.016.2412.381332.119.166.3313.5511.5712.7921.9517.997.38
Debt to equity ratio0.010.020.150.230.160.170.320.340.490.540.700.601.390.830.720.640.640.700.480.32
Return on equity %012.759.317.4513.8625.0318.183.246.060.35-0.87-8.3325.0862.6421.9713.584.22-14.86-7.6423.59

Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio

The Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Fermenta Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Fermenta Biotech Ltd (NSE: , BSE: 506414) is currently trading at ₹336.60, with a market capitalization of ₹9.99B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio Current Value

The current Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio stands at 7.38.

The Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

  • 2024: 7.38
  • 2023: 17.99
  • 2022: 21.95
  • 2021: 12.79
  • 2020: 11.57

The decline in Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Fermenta Biotech Ltd.

Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Fermenta Biotech Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800